VIOXX Drug Patent Profile

✉ Email this page to a colleague

When do Vioxx patents expire, and when can generic versions of Vioxx launch?

Vioxx is a drug marketed by Merck and is included in two NDAs.

The generic ingredient in VIOXX is rofecoxib. There are two drug master file entries for this compound. Additional details are available on the rofecoxib profile page.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for VIOXX?
What are the global sales for VIOXX?
What is Average Wholesale Price for VIOXX?

Summary for VIOXX

US Patents:	0
Applicants:	1
NDAs:	2
Raw Ingredient (Bulk) Api Vendors:	115
Patent Applications:	4,524
DailyMed Link:	VIOXX at DailyMed

Drug patent expirations by year for VIOXX

US Patents and Regulatory Information for VIOXX

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Merck	VIOXX	rofecoxib	SUSPENSION;ORAL	021052-001	May 20, 1999		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Merck	VIOXX	rofecoxib	TABLET;ORAL	021042-002	May 20, 1999		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Merck	VIOXX	rofecoxib	SUSPENSION;ORAL	021052-002	May 20, 1999		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Merck	VIOXX	rofecoxib	TABLET;ORAL	021042-001	May 20, 1999		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Merck	VIOXX	rofecoxib	TABLET;ORAL	021042-003	Feb 25, 2000		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for VIOXX

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Merck	VIOXX	rofecoxib	TABLET;ORAL	021042-002	May 20, 1999	⤷ Sign Up	⤷ Sign Up
Merck	VIOXX	rofecoxib	TABLET;ORAL	021042-002	May 20, 1999	⤷ Sign Up	⤷ Sign Up
Merck	VIOXX	rofecoxib	TABLET;ORAL	021042-001	May 20, 1999	⤷ Sign Up	⤷ Sign Up
Merck	VIOXX	rofecoxib	SUSPENSION;ORAL	021052-001	May 20, 1999	⤷ Sign Up	⤷ Sign Up
Merck	VIOXX	rofecoxib	TABLET;ORAL	021042-003	Feb 25, 2000	⤷ Sign Up	⤷ Sign Up
Merck	VIOXX	rofecoxib	SUSPENSION;ORAL	021052-001	May 20, 1999	⤷ Sign Up	⤷ Sign Up
Merck	VIOXX	rofecoxib	SUSPENSION;ORAL	021052-002	May 20, 1999	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for VIOXX

See the table below for patents covering VIOXX around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Yugoslavia	40394		⤷ Sign Up
Czech Republic	291463	Farmaceutický prostředek (Pharmaceutical composition)	⤷ Sign Up
Slovakia	284330		⤷ Sign Up
Australia	711902		⤷ Sign Up
Hungary	227913	PHENYL HETEROCYCLES AS CYCLOOXYGENASE-2 INHIBITORS	⤷ Sign Up
Poland	188649		⤷ Sign Up
China	1225010		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for VIOXX

Make Better Decisions: Try a trial or see plans & pricing